Ligand to Hold Fourth Quarter Results Conference Call on February 12
SAN DIEGO-- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that it plans to report fourth quarter 2008 financial results on Thursday, February 12, 2009, following the close of market. Ligand's President and CEO, John L. Higgins, Vice President of Finance and CFO, John Sharp and Vice President of Discovery Research,
Dr. Martin Meglasson will host the conference call.
What: Ligand Pharmaceuticals conference call to discuss financial results and provide general business updates. When: Thursday, February 12, 2009 Time: 1:30 p.m. Pacific time (4:30 p.m. Eastern time) Webcast: Conference call and replay accessible at www.ligand.com. Conference Call: (877) 356-5578, ID # 82608477 (U.S.) Replay: (800) 642-1687, ID # 82608477 (U.S.) Replay of conference call will be available from February 12, 2009 to March 12, 2009.
About Ligand Pharmaceuticals
Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases and anemia. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology.
Source: Ligand Pharmaceuticals Incorporated
Released January 29, 2009